fluocortolone has been researched along with Basedow Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eckstein, AK; Esser, J; Johnson, KT; Loesch, C; Sauerwein, W; Wittig, A | 1 |
Eckstein, AK; Esser, J; Hirche, H; Lax, H; Mann, K; Morgenthaler, NG; Plicht, M; Quadbeck, B; Steuhl, KP | 1 |
Nüssgens, Z; Roggenkämper, P; Schweikert, HU | 1 |
Benker, G; Esser, J; Molls, M | 1 |
4 other study(ies) available for fluocortolone and Basedow Disease
Article | Year |
---|---|
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Enzyme-Linked Immunosorbent Assay; Female; Fluocortolone; Glucocorticoids; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Middle Aged; Orbital Diseases; Prednisolone; Radiation Monitoring; Radiotherapy Dosage; Retrospective Studies; Thyrotropin; Thyroxine; Treatment Outcome | 2010 |
Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Topics: Anti-Inflammatory Agents; Autoantibodies; Female; Fluocortolone; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Iodide Peroxidase; Iodine Radioisotopes; Logistic Models; Male; Middle Aged; Receptors, Thyrotropin; Retrospective Studies; Thyroglobulin; Thyroid Gland; Time Factors | 2004 |
[Development of endocrine orbitopathy in pregnancy].
Topics: Adult; Cobalt Radioisotopes; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fluocortolone; Follow-Up Studies; Graves Disease; Humans; Pregnancy; Pregnancy Complications; Puerperal Disorders; Radioisotope Teletherapy | 1993 |
[Quantitative results following consecutive corticoid and radiotherapy in endocrine ophthalmopathy].
Topics: Combined Modality Therapy; Fluocortolone; Graves Disease; Humans; Orbit | 1988 |